Skip to main content
SpringerLink
Log in

Prescribing indicators in primary health care in Belo Horizonte, Brazil: associated factors

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background The prescription is one of the factors that influences rational use of medicines. The evaluation of prescribing indicators should contribute to organization of primary health care services. Objective The aim of this study was to evaluate prescribing indicators and associated factors in primary health care in the northeast health district, Belo Horizonte, Brazil. Setting Twenty primary health care units in the Northeast Health District, Belo Horizonte, Brazil. Method The study was cross sectional. Indicators proposed by World Health Organization were used to evaluate rational use of medicines. Main outcome measure Indicators evaluated were average number of medicines per prescription, proportion of medicines with antibiotic, injectable, medicines prescribed by generic name and medicines present in the essential medicines list. Results Three hundred and ninety-nine patients were interviewed. The average number of medicines per prescription was 3.5 (SD 2.2). The proportion of medicines with antibiotic, injectable, medicines prescribed by generic name and medicines present in the essential medicines list was 17.8, 9.8, 94.9, 91.4%, respectively. Patient age ≥60 years was positively associated with number of medicines per prescription (P = 0.00). Conclusion In the northeast health district of Belo Horizonte, the proportion of prescriptions of antibiotics and injections, the adoption of prescribing by generic name and the prescribing of essential medicines were satisfactory in this study considering reference values for these indicators and international scientific literature. However, the mean number of prescribed medicines requires a more in-depth evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pan American Health Organization. Renewing primary health care in the Americas: a position paper of the Pan American Health Organization. Washington: PAHO; 2007. http://apps.who.int/medicinedocs/documents/s19055en/s19055en.pdf. Accessed 10 June 2017.

    Google Scholar 

  2. World Health Organization. The rational use of drugs: report of the Conference of Experts Nairobi, 25–29 November 1985. Geneva: WHO; 1987. http://apps.who.int/medicinedocs/documents/s17054e/s17054e.pdf. Accessed 10 June 2017.

    Google Scholar 

  3. Management Sciences for Health. Managing access to medicines and health technologies. Arlington: Management Sciences for Health; 2012. http://apps.who.int/medicinedocs/documents/s19577en/s19577en.pdf. Accessed 10 June 2017.

    Google Scholar 

  4. World Health Organization. The world medicines situation 2011. Geneva: WHO; 2011. http://www.who.int/medicines/areas/policy/world_medicines_situation/WMS_ch6_wPricing_v6.pdf. Accessed 10 June 2017.

    Google Scholar 

  5. Chaturvedi VP, Mathur AG, Anand AC. Rational drug use—As common as common sense? Med J Armed Forces India. 2012;68(3):206–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63(2):136–47.

    Article  CAS  PubMed  Google Scholar 

  7. Sultana J, Cutroneo P, Trifirò G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(Suppl1):S73–7.

    Article  PubMed  PubMed Central  Google Scholar 

  8. World Health Organization. How to investigate drug use in health facilities: selected drug use indicators. Action Programme on Essential Drugs. Geneva: World Health Organization; 1993. http://apps.who.int/medicinedocs/en/d/Js2289e/. Accessed 10 June 2017.

  9. World Health Organization. WHO operational package for assessing, monitoring and evaluating country pharmaceutical situations: guide for coordinators and data collectors. Geneva: WHO; 2007. http://www.who.int/medicines/publications/WHO_TCM_2007.2.pdf. Accessed 10 June 2017.

    Google Scholar 

  10. Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015). BMC Public Health. 2016;16:724.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Dumoulin J, Kaddar M, Velásquez G. Guide to drug financing mechanisms. Geneva: World Health Organization; 1998. http://apps.who.int/medicinedocs/en/d/Jh2928e/. Accessed 10 June 2017.

    Google Scholar 

  12. Harvard Medical School and Harvard Pilgrim Health, World Health Organization. Using indicators to measure country pharmaceutical situations Fact Book on WHO Level I and Level II monitoring indicators. Geneva: World Health Organization; 2006. http://www.who.int/medicines/publications/WHOTCM2006.2A.pdf. Accessed 10 June 2017.

    Google Scholar 

  13. Holloway KA, Ivanovska V, Wagner AK, Vialle-Valentin C, Ross-Degman D. Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence. Trop Med Int Health. 2013;18(6):656–64.

    Article  CAS  PubMed  Google Scholar 

  14. Desalegn AA. Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: a cross-sectional study. BMC Health Serv Res. 2013;13:170.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Emmerick IC, Luiza VL, Pepe VL. Pharmaceutical services evaluation in Brazil: broadening the results of a WHO methodology. Cien Saude Colet. 2009;14(4):1297–306.

    Article  PubMed  Google Scholar 

  16. Dong L, Yan H, Wang D. Drug prescribing indicators in village health clinics across 10 provinces of Western China. Fam Pract. 2011;28(1):63–7.

    Article  PubMed  Google Scholar 

  17. Siddiqi S, Hamid S, Rafique G, Chaudhry S, Ali N, Shahab S, et al. Prescription practices of public and private health care providers in Attock District of Pakistan. Int J Health Plann Manage. 2002;17(1):23–40.

    Article  CAS  PubMed  Google Scholar 

  18. Secretaria Municipal de Saúde de Belo Horizonte. Plano Municipal de Saúde 2014-2017 [Municipal Health Plan 2014-2017]. Belo Horizonte: Secretaria Municipal de Saúde de Belo Horizonte; 2014.

    Google Scholar 

  19. Farias AD, Cardoso MAA, Medeiros ACD, Belém LF, Simões MOS. Indicadores de prescrição médica nas unidades básicas de Saúde da Família no município de Campina Grande, PB [Prescription indicators in Family Health basic units of the municipal district of Campina Grande, PB]. Rev Bras Epidemiol. 2007;10(2):149–56.

    Article  Google Scholar 

  20. Lima-Costa MF, Matos DL, Camargos VP, Macinko J. Tendências em dez anos das condições de saúde de idosos brasileiros: evidências da Pesquisa Nacional por Amostra de Domicílios (1998, 2003, 2008) [10-year trends in the health of Brazilian elderly: evidence from the National Household Sample Survey (PNAD 1998, 2003, 2008)]. Cien Saude Colet. 2011;16(9):3689–96.

    Article  PubMed  Google Scholar 

  21. Ojo MA, Igwilo CI, Emedoh T. Prescribing patterns and perceptions of health care professionals about rational drug use in a specialist hospital clinic. J Public Health Afr. 2014;5(2):242.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Social Pharmacy, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil

    Marina Guimarães Lima & Ursula Carolina Morais Martins

  2. Post Graduation Programme in Medicines and Pharmaceutical Services, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil

    Kátia Reis Dutra

Authors
  1. Marina Guimarães Lima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kátia Reis Dutra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ursula Carolina Morais Martins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marina Guimarães Lima.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lima, M.G., Dutra, K.R. & Martins, U.C.M. Prescribing indicators in primary health care in Belo Horizonte, Brazil: associated factors. Int J Clin Pharm 39, 913–918 (2017). https://doi.org/10.1007/s11096-017-0501-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-017-0501-z

Keywords

Search

Navigation